Author:
Olivera-Bravo Silvia,Bolatto Carmen,Otero Damianovich Gabriel,Stancov Matías,Cerri Sofía,Rodríguez Paola,Boragno Daniela,Hernández Mir Karina,Cuitiño María Noel,Larrambembere Fernanda,Isasi Eugenia,Alem Diego,Canclini Lucía,Marco Marta,Davyt Danilo,Díaz-Amarilla Pablo
Abstract
AbstractAmyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive death of motor neurons and muscle atrophy, with defective neuron-glia interplay and emergence of aberrant glial phenotypes having a role in disease pathology. Here, we have studied if the pigment violacein with several reported protective/antiproliferative properties may control highly neurotoxic astrocytes (AbAs) obtained from spinal cord cultures of symptomatic hSOD1G93A rats, and if it could be neuroprotective in this ALS experimental model. At concentrations lower than those reported as protective, violacein selectively killed aberrant astrocytes. Treatment of hSOD1G93A rats with doses equivalent to the concentrations that killed AbAs caused a marginally significant delay in survival, partially preserved the body weight and soleus muscle mass and improved the integrity of the neuromuscular junction. Reduced motor neuron death and glial reactivity was also found and likely related to decreased inflammation and matrix metalloproteinase-2 and -9. Thus, in spite that new experimental designs aimed at extending the lifespan of hSOD1G93A rats are needed, improvements observed upon violacein treatment suggest a significant therapeutic potential that deserves further studies.
Funder
IIBCE - Ministry of Education and Culture
PEDECIBA
Agencia Nacional de Investigación e Innovación
UdelaR
Publisher
Springer Science and Business Media LLC
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献